Tuesday, January 27, 2009

Bio Farma prepare a bird flu vaccine

[google & toggletext translations]

google translation:
Wednesday, 28/01/2009


BANDUNG: PT Bio Farma launched a plan on bird flu vaccine this year. Vaccines are one of four new vaccines which will be launched in addition to tetanus diphtheria vaccine (TD), petavalent (DTP / HB + Hib) and DtaP.

During this vaccine is imported from France and the United States. "We work with a Japanese research institute to develop bird flu vaccine since 3 years ago," said Corporate Secretary PT Bio Farma Rahman Rustan, recently.

Currently, he said, seasonal flu vaccine is given to the candidates Jamaah Hajj.

He explains strain of virus or virus specific tribe's seasonal flu vaccine will be developed in accordance with their needs in case of bird flu pendemik.

"Development of seasonal flu vaccines need a long time because of issues related to technology research development virusnya."

Bio Farma has now entered the final stage of the development of a field test of the seasonal flu vaccine. Therefore, he is optimistic the vaccine could be launched in 2009.

"Basically, we do not want to have pendemik bird flu in Indonesia. However, if the worst case occurs, for example, a bird flu outbreak occurs we are ready to prepare the vaccine," said Rahman.

Associated with the development of other types of vaccine, the vaccine petavalen Rahman is five antivirus which is packed in a single vaccine. Appropriate name, this vaccine to prevent the disease diphtheria, tetanus, pertussis, hepatitis B and influenza type B. haemofilus

The vaccine DtaP, he said, is antidifteri and tetanus in the form of antiseluler. Development of the vaccine has the potential of the market. The results of our study is needed antidifteri this community, at least for the market in the country.

Other vaccine

Bio Farma, he said, also are developing a number of vaccines, among others, targeted rubella vaccine can be marketed in 2010, the vaccine Ratarius in 2010, Sabin inactivated polio vaccin (IPV) vaccine in 2011 and Pneumococ which is scheduled to be launched in 2012.

Previously, Director of Planning and Development of Bio Farma Iskandar said Sabin vaccine production process IPV (polio vaccine needle) has entered the experimental phase.

"We started targeting Sabin IPV tested in humans began in 2011," he said, has not been this long.

Era polio vaccine drops, he said, will be ended in line with the target World Health Organization (WHO) that a world free of polio in 2013.

Instead of polio vaccine drops, at this time Bio Farma research center polio vaccine production is estimated to need a needle funds around Rp300 billion. "Around Rp15 billion of which is used for the purposes of research," he said.

Bio Farma to work together with Japan Polio Myelitis Research Institute in Japan to research polio vaccine this needle.

According to him, compared to drops of polio vaccine, Sabin IPV is much more effective. (k37)

Bisnis Indonesia


toggletext translation:

PT Bio Farma planned to launch the bird flu vaccine in this year. This vaccine was one from four new vaccines that will be launched apart from the vaccine of diphtheria tetanus (TD), petavalent (DTP/HB+HIB) and DtaP.

Uptil now this vaccine was imported from France and the United States. "We co-operated with a Japanese research agency to develop the bird flu vaccine since the last 3 years," said Corporate Secretary PT Bio Farma Rahman Rustan, recently.

At this time, said he, the vaccine seasonal flu has been given to the prospective congregations of the pilgrim. He explained strain the virus or the certain virus ethnic group from the vaccine seasonal flu can be eventually developed in accordance with the requirement if happening pendemik bird flu.

The "development" of the "vaccine seasonal flu needed in sufficient time because related the problem" of the "research" of "his virus of development technology." Bio Farma currently enters the stage of the development end took the form of the field test from the vaccine seasonal flu. Therefore, he was optimistic this vaccine could be launched 2009. "Basically, we did not want was pendemik bird flu in Indonesia." However, if the worst case happening, for example, the plague of our bird flu happened has been ready to prepare his vaccine, Merciful words.

In relation to the development of the other vaccine kind, Merciful explained the vaccine petavalen was five antivirus that was packed in one vaccine. In accordance with his name, this vaccine to prevent the diphtheria illness, tetanus, pertusis, B hepatitis and haemofilus B type influenza. As for the vaccine DtaP, said he, was antidifteri and tetanus in the form of antiseluler. The development of this vaccine through potential investigation for the market. From results of our study antidifteri this really was needed by the community, at least for the market in the country.

The vaccine lain Bio Farma, he said, also was developing several vaccines including the Rubella vaccine that was aimed at could be marketed in 2010, the Ratarius vaccine in 2010, Sabin inactivated polio vaccin (IPV) in 2011 and the Pneumococ vaccine that was scheduled to be launched in 2012.

Beforehand, Director Perencanaan and the Bio Farma Iskandar Development said the process of the production of the Sabin IPV vaccine (the polio vaccine suntik) at this time entered the experimental stage. "We aimed at Sabin IPV began to be tested to humankind from 2011," he said, just recently. The era of the vaccine of drop polio, he said, will end together with the Organisation target of the Health of the World (WHO) that proclaimed the free world of polio in 2013.

As the substitute for the vaccine of drop polio, at this time Bio Farma was carrying out the production research of the polio vaccine suntik that it was estimated needed the fund around Rp300 billion. "Around Rp15 billion including being used for the interests" of the "research," he said. Bio Farma carried out the work was the same as Japan Polio Myelitis Research Institut in Japan to carry out the research of the polio vaccine suntik this. According to him, was compared the vaccine of drop polio, Sabin IPV this was far more effective. (k37)

No comments: